In good agreement with this finding, in our experimental system, 5-day human moDCs expressed CD83 and CD86 at a higher level and produced TNFα, IL-1β, IL-6, and IL-8 upon L. casei CFS treatment. The gene discussed is CD83; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.